Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jutatip Panaampon

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Exploration of Targeted Anti-Tumor Therapy|July 5, 2024
Promising immunotherapeutic approaches for primary effusion lymphomaJutatip Panaampon, Seiji Okada
Cancer Immunology, Immunotherapy : CII|March 9, 2022
Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cellsJutatip Panaampon, Ryusho Kariya, Seiji Okada
Cancer Immunology, Immunotherapy : CII|September 21, 2021
Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphomaJutatip Panaampon, Ryusho Kariya, Seiji Okada
International Immunopharmacology|June 26, 2023
Metformin as a booster of cancer immunotherapyJutatip Panaampon, Yubin Zhou, Charupong Saengboonmee
World Journal of Gastrointestinal Oncology|May 20, 2024
Interleukin-1β: Friend or foe for gastrointestinal cancersKullanat Khawkhiaw, Jutatip Panaampon, Thanit Imemkamon, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 28, 2021
Establishment of Nude Mice Lacking NK Cells and Their Application for Human Tumor XenograftsJutatip Panaampon, Kenichi Sasamoto, Ryusho Kariya, et al.
Transgenic Research|June 14, 2026
Transgenic expression of human signal regulatory protein alpha (SIRPα) in BALB/c Rag2<sup>null</sup>/Jak3<sup>null</sup> immunodeficient mice enhances human lymphoma xenografts by reducing phagocytosisJutatip Panaampon, Tatsuya Ogawa, Akira Shiota, et al.
Heliyon|November 6, 2019
Ephedrine enhances HIV-1 reactivation from latency through elevating tumor necrosis factor receptor II (TNFRII) expressionJutatip Panaampon, Eriko Kudo, Ryusho Kariya, et al.
Progress in Molecular Biology and Translational Science|October 26, 2024
Magnetic nanoparticles: An emerging nanomedicine for cancer immunotherapyPhoomipat Jungcharoen, Jutatip Panaampon, Thanit Imemkamon, et al.
Anticancer Research|February 28, 2023
Dihydroartemisinin Induced Apoptosis and Synergized With Chemotherapy in Pleural Effusion Lymphoma CellsPloyploen Phikulsod, Ryusho Kariya, Jutatip Panaampon, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Exploration of Targeted Anti-Tumor Therapy|July 5, 2024
Promising immunotherapeutic approaches for primary effusion lymphomaJutatip Panaampon, Seiji Okada
Cancer Immunology, Immunotherapy : CII|March 9, 2022
Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cellsJutatip Panaampon, Ryusho Kariya, Seiji Okada
Cancer Immunology, Immunotherapy : CII|September 21, 2021
Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphomaJutatip Panaampon, Ryusho Kariya, Seiji Okada
International Immunopharmacology|June 26, 2023
Metformin as a booster of cancer immunotherapyJutatip Panaampon, Yubin Zhou, Charupong Saengboonmee
World Journal of Gastrointestinal Oncology|May 20, 2024
Interleukin-1β: Friend or foe for gastrointestinal cancersKullanat Khawkhiaw, Jutatip Panaampon, Thanit Imemkamon, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 28, 2021
Establishment of Nude Mice Lacking NK Cells and Their Application for Human Tumor XenograftsJutatip Panaampon, Kenichi Sasamoto, Ryusho Kariya, et al.
Transgenic Research|June 14, 2026
Transgenic expression of human signal regulatory protein alpha (SIRPα) in BALB/c Rag2<sup>null</sup>/Jak3<sup>null</sup> immunodeficient mice enhances human lymphoma xenografts by reducing phagocytosisJutatip Panaampon, Tatsuya Ogawa, Akira Shiota, et al.
Heliyon|November 6, 2019
Ephedrine enhances HIV-1 reactivation from latency through elevating tumor necrosis factor receptor II (TNFRII) expressionJutatip Panaampon, Eriko Kudo, Ryusho Kariya, et al.
Progress in Molecular Biology and Translational Science|October 26, 2024
Magnetic nanoparticles: An emerging nanomedicine for cancer immunotherapyPhoomipat Jungcharoen, Jutatip Panaampon, Thanit Imemkamon, et al.
Anticancer Research|February 28, 2023
Dihydroartemisinin Induced Apoptosis and Synergized With Chemotherapy in Pleural Effusion Lymphoma CellsPloyploen Phikulsod, Ryusho Kariya, Jutatip Panaampon, et al.
Pageof 4